Emerging Antiseptic Resistance in ICUs
The use of CHG as an antiseptic for patient baths in ICUs is increasing consistently in hospitals. It is believed that CHG may reduce the spread of multi-drug resistant organisms and prevent central line associated bloodstream infections (CLABSIs). However, it is unclear as to how the microbial ecology of the human microbiome and hospital environment will adapt to this expanded usage. There already have been reports of bacteria isolates that have demonstrated reduced CHG susceptibility.
The study was led by investigators at John Hopkins who compared bacterial resistance between cultures from patients in eight ICUs receiving daily antiseptic washes to patients in 30 non-ICUs who did not bathe daily with CHG. One hundred and fifty bacterial isolates were recovered from patients with CLABSIs between January 2012 and September 2013. 122 isolates were tested for CHG susceptibility from 28 patients in units with daily CHG bathing and 96 patients from units with no CHG bathing.
The cultures from patients with regular antiseptic baths showed reduced susceptibility to CHG as compared to those from patients who did not have antiseptic baths. Sixty nine percent of all bacteria showed a reduced susceptibility to CHG, regardless of unit protocol.
According to Nuntra Suwantarat, MD, and lead author of this study, "Hospitals are appropriately using chlorhexidine to reduce infections and control the spread of antibiotic-resistant organisms. However, our findings are a clear signal that we must continue to monitor bacteria for emerging antiseptic resistance as these antibacterial washes become more widely used in hospitals."
However, the clinical implications of these findings are yet unclear. Antibiotic susceptibility tests are often used to determine whether patients will respond to a certain antibiotic treatment. To date, there is no well-defined correlation between antiseptic susceptibility and response to an antiseptic and this is the area which should be further explored in future. These recent findings indicate that there is a need to evaluate the effectiveness of using CHG and to monitor bacterial resistance vigilantly.
The good news though is that despite reduced susceptibility, most bacteria are still vulnerable to CHG. Daily bathing with the CHG solution is an effective strategy against life-threatening bloodstream infections. In any case, this issue should be further explored. The next step should involve the identification of particular bacteria and settings in which these bacteria do not respond to antiseptic agents.
Source: Medical News Today
Image Credit: Google images
Published on : Sun, 17 Aug 2014
Right when it matters. Right where it counts. Simplify assessments and deliver effective care with Venue Go. Featuring a uniquely adaptable design that goes from cart to table to wall, Venue Go supports Point of Care medicine across...
The iLA membrane ventilator is an extrapulmonary ventilation system which is used to remove carbon dioxide. The heart pumps blood through the iLA membrane ventilator as it does through a natural organ. The iLA membrane ventilator “breathes” outside...
Extracorporeal organ support for enhanced patient well-being Dedicated technology combines both heart and lung support in one single platform – a platform that is universally usable, individual, safe, and compatible with applications of our parent...
The Evolution of Simplicity Inspired by the needs of customers, Mindray patient monitors adopt advanced technologies and transform them into accessible innovation. The ePM delivers excellent visual experience, intelligent operation, accurate...